Saving changes...

Done

Error

Optimizing Antiplatelet Therapy in the High Risk Cardiovascular Patient

Optimizing Antiplatelet Therapy in the High Risk Cardiovascular Patient

Optimizing Antiplatelet Therapy in the High Risk Cardiovascular Patient

David Anderson MS, MD, FACC, FSCAI
David Anderson MS, MD, FACC, FSCAI
on behalf of Preventive Cardiovascular Nurses Association

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 04 Jan 2018
Expiry Date:

Last updated: 06 Dec 2018

Reference: 185876

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

With 1.7 million hospital discharges per year, acute coronary syndrome constitutes a significant burden of health. In this on-demand CE course, you will learn the classes of anti-platelet therapies, review clinical trial data, learn about guideline-based use, and hear case presentations. -

Objectives

On completion of this course, the learner will be able to:
1. Identify the guidelines for dual antiplatelet therapy in the post-ACS patient

2. Identify the indications in which the risk of ASCFD outweighs the risk of bleeding, justifying the addition of a PAR-1 antagonist to standard dual oral antiplatelet therapy

3. List three classes of antiplatelet agents
David Anderson MS, MD, FACC, FSCAI

Author Information Play Video Bio

David Anderson MS, MD, FACC, FSCAI
on behalf of Preventive Cardiovascular Nurses Association

Dr. Anderson is professor of medicine in the division of cardiovascular medicine at the University of Florida in Gainesville. He received his Medical training at Hopkins, Duke University and the University of Maryland. He serves as Director of the interventional cardiology fellowship training program at the University of Florida. He has received numerous awards for his excellence in teaching and was awarded the Master Clinician Award at the University of Florida in 2013. He has been the principal investigator of numerous clinical investigations of evaluating safety and efficacy of percutaneous interventions. His clinical interest include: Cardiac catheterization, carina heart disease, peripheral artery disease and transcatheter aortic valve replacement.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • American Association of Nurse Practitioners (AANP)
  • 1.00 Hours -
    Exam Pass Rate: 70

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error